Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1915890Generated: November 1, 2026

Diisopropylethylamine → HCID 89456493, compound

https://huagongshe.com/reaction/1915890

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
ReactantPyBOPHCID 2724699—
Reactant5-((Tert-butoxycarbonyl)amino)-2-(2,6-difluorophenyl)thiazole-4-carboxylic acidHCID 67438198—
ReactantHCID 89456508HCID 89456508—
SolventDichloromethaneHCID 6344—
ProductHCID 89456493HCID 89456493—

Reaction Steps

To a cooled (ice-water bath) solution of Intermediate 44, tert-butyl 6-hydroxy-6-methyl-4-(1-methyl-4-nitro-1H-pyrazol-5-yl)-1,4-diazepane-1-carboxylate (70 mg, 0.20 mmol) in DMF (1 mL) under nitrogen, was added sodium hydride (60% in mineral oil, 9.5 mg, 0.24 mmol) and the mixture stirred for 10 min. Iodomethane (0.04 mL, 0.6 mmol) was added and the mixture stirred at room temperature for 16 hr. Additional sodium hydride (60% in mineral oil, 9.5 mg, 0.24 mmol) was added and the mixture stirred for 30 min before the addition of more iodomethane (0.04 mL, 0.6 mmol). After 5 hr, water (30 mL) was added and the mixture extracted with EtOAc (2×5 mL). The combined organic layers were dried over Na2SO4 and the solvent removed under reduced pressure to afford tert-butyl 6-methoxy-6-methyl-4-(1-methyl-4-nitro-1H-pyrazol-5-yl)-1,4-diazepane-1-carboxylate as an oil. A solution of this oil in MeOH (4 mL) was passed through the H-Cube® (full H2, 60° C., flow rate: 1 mL/min, 30 mm 10% Pd/C cartridge). The solvent was removed under reduced pressure to afford tert-butyl 4-(4-amino-1-methyl-1H-pyrazol-5-yl)-6-methoxy-6-methyl-1,4-diazepane-1-carboxylate as an oil. To a solution of this amine in DCM (10 mL) was added DIPEA (0.1 mL, 9.6 mmol), PyBOP (160 mg, 0.30 mmol) and 5-(tert-butoxycarbonylamino)-2-(2,6-difluorophenyl)thiazole-4-carboxylic acid from Example 25 (78 mg, 0.22 mmol) and the mixture was stirred at room temperature for 18 hr. The mixture was diluted with DCM (30 mL) and washed with water (20 mL). The organic layer was separated, dried over MgSO4 and the solvent removed under reduced pressure. Purification via silica gel column chromatography (75% EtOAc/isohexane) gave tert-butyl 4-(4-(5-(tert-butoxycarbonylamino)-2-(2,6-difluorophenyl)thiazole-4-carboxamido)-1-methyl-1H-pyrazol-5-yl)-6-methoxy-6-methyl-1,4-diazepane-1-carboxylate as a beige solid (123 mg). This solid (120 mg, 0.30 mmol) was stirred with HCl in 1,4-dioxane (4 M, 2.3 mL, 9.1 mmol) in MeOH (1 mL) at room temperature for 16 hr. The solvents were removed under reduced pressure and the crude residue was re-dissolved in MeOH and loaded onto an SCX column. The column was washed with MeOH and eluted with 7 N ammonia in MeOH and the residue was purified via silica gel column chromatography (0-10% MeOH/DCM, 1% 7 N ammonia in MeOH). Further purification by preparative HPLC gave 192 as the monoformate salt as an off-white solid (19 mg, 20% over four steps). 1H NMR (400 MHz, d6-DMSO) δ 9.38 (s, 1H), 8.21 (s, 1H), 7.66 (s, 1H), 7.60-7.48 (m, 3H), 7.33-7.23 (m, 2H), 3.67 (t, J=4.9 Hz, 3H), 3.29-2.69 (m, 11H), 0.97 (s, 3H). Alkyl NH not observed. LCMS (ES+) m/z 477 (M+1).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08614206B2
Source datasetuspto-grants-2013_12
ORD IDord-17ea9a6f1bc44b0db07e3d9058e332cd
Source noteuspto-grants-2013_12